Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-042429

Director sold 250 shares at $15.20 ($3,801)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Johnson Craig A Director 2021-06-21 Sale −250 $15.20 $3,801 3,340 D: show line 1 in the form
Open-market sales · 250 sh · avg $15.20 · $3,801
Loading xslF345X03/doc4.xml…